Article

Benchmarking GNNs for Blood-Brain Barrier Permeability Prediction

2023-01-23

Abstract excerpt

<title>Abstract</title> <p>With the burden of deaths and disability caused by neurological disorders like Alzheimer's disease, Parkinson’s disease, and epilepsy on the rise, speeding up the novel neurotherapeutic drug discovery process becomes crucial. Determining whether a drug is blood-brain barrier permeable or not is a prerequisite for discovering all central nervous system (CNS) drugs. Accurate and high thro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bd30f84a-edfa-5de7-afb7-39e449472b9d
DOI: 10.21203/rs.3.rs-2503574/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Benchmarking GNNs for Blood-Brain Barrier Permeability PredictionDOI 10.21203/rs.3.rs-2503574/v1Read

MGATAF: Multi-channel Graph AttentionNetwork with Adaptive Fusion forCancer-Drug Response PredictionSemantic proximity Read

A Hybrid Graph Neural Network and Physiologically Based Pharmacokinetic Framework for Multi-Drug Concentration Prediction with Explainability and Uncertainty QuantificationSemantic proximity Read

Multi-Task Graph Neural Network For Alzheimer’s Disease Drug Repurposing Using Knowledge Graph And Multi-Level EvidenceSemantic proximity Read

Multilayered validation of graph attention autoencoder–derived drug repurposing candidates for COVID-19Semantic proximity Read

Novel graph attention autoencoder framework with multilayered validation identifies drug repurposing candidates for COVID-19 treatmentSemantic proximity Read

DeepEAG: An edge-powered graph neural network using SMILES augmentation for cancer drug response predictionSemantic proximity Read

Algebraic Graph-assisted Bidirectional Transformers for Molecular PredictionSemantic proximity Read

Coloring Molecules with Explainable Artificial Intelligence for Preclinical Relevance AssessmentSemantic proximity Read

Drug repurposing for rare diseases via a gene-bridged heterogeneous knowledge graph and graph attention networkSemantic proximity Read

MultiGML: Multimodal Graph Machine Learning for Prediction of Adverse Drug EventsSemantic proximity Read

Overcoming Topology Bias and Cold-Start Limitations in Drug Repurposing: A Clinical-Outcome-Aligned LLM FrameworkSemantic proximity Read

Synthesize Heterogeneous Biological Knowledge via Representation Learning for Alzheimer’s Disease Drug RepurposingSemantic proximity Read